Tuesday 3 September 2019

3D Medical Imaging Devices Market - Industry Analysis and Outlook, 2026

The global 3D Medical Imaging Devices Market size is expected to reach USD 20.8 billion by 2026, according to a new report by Grand View Research, Inc. It is anticipated to register a CAGR of 5.9% during the forecast period. High prevalence of cancer, cardiovascular diseases, and Alzheimer’s among other chronic diseases is projected to drive the growth. Rise in healthcare expenditure across developed economies and rapid technological advancements are other prime factors responsible for the market growth.
Few noteworthy technological advancements include development of imaging systems with low radiation levels and increasing approvals of contrast and media/agents. For instance, in April 2016, Bracco Diagnostics, a U.S. based subsidiary of Bracco Imaging S.p.A., an Italian giant in the 3D imaging; received approval from the U.S. Food and Drug Administration (FDA) for its new ultrasound contrast agent Lumason, for pediatric and adult patients. In another instance, Germany based healthcare company, Bayer Healthcare received FDA approval in May 2016 for Gadovist injection used in the angiography procedures in U.S. Such factors are expected to bode well for the global market growth over the forecast period.

Germany 3D medical imaging devices market
However, the 3D medical imaging devices market is restrained due to the high cost of devices and the shortage of helium used in the cooling of MRI scanners.
Further key findings from the report suggest:
  • By type, computed tomography emerged as the largest segment in 2017 owing to the rise in road traffic accidents
  • Orthopedic led the application segment owing to the global rise in old age population with musculoskeletal problems
  • Rise in healthcare expenditure in emerging markets, such as India and China coupled with awareness regarding early diagnosis are key factors propelling growth of the 3D medical imaging devices market
  • North America held the largest market share in 2017. Growing adoption of minimally invasive surgeries and demand for novel technologies are expected to support this dominance during the forecast period
  • Asia Pacific is projected to witness swift growth during the forecast period owing to the rapidly improving healthcare infrastructure and the presence of large patient population
  • Few of the key market players include Siemens Healthineers; Philips Koninklijke; GE Healthcare Ltd.; Hitachi Medical Systems; Del Medical Systems Inc.; and DigiRad Corporation.


About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James

Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email:
sales@grandviewresearch.com
For More Information:
https://www.grandviewresearch.com
Blog:  https://healthcareforecastreport.blogspot.com/

No comments:

Post a Comment

Insulin Delivery Devices Market To Reach $28.06 Billion By 2030

  The global  Insulin Delivery Devices Market  size was estimated at USD 28.06 billion in 2030 and is expected to grow at a CAGR of 7.89% fr...